The TriMark Point of Care Testing Conference 2009 has been organized to provide a critical examination of the point of care industry, as well as valuable insights from key industry leaders concerning new cutting edge point of care technologies, and the impact on clinical medicine. This conference will also provide a forum for leaders in point of care technology sector, point of care coordinators, laboratory directors and clinical laboratorians to share ideas, network with other delegates and advance understanding of the potential of new point of care technologies for improving medical care delivery.
Who Should Attend :
-
Point of care coordinators.
-
Medical technologists and laboratorians.
-
Laboratory directors and supervisors.
-
Point of care technology development companies.
-
Physicians and clinical scientists.
-
Industry representatives and researchers.
-
Regulatory personnel.
Leaders from the Following Areas Will Greatly Benefit from Attending :
-
Laboratory leaders.
-
Hospital CFOs and CSOs.
-
Point of care and in vitro diagnostic companies.
-
Business development.
-
Strategic planning and development.
-
Technology development.
-
Marketing.
-
Research and development.
Key Themes :
-
A critical examination of key emerging technologies in to point of care testing.
-
Transitioning from laboratory in vitro diagnostics to point of care diagnostics.
-
Evidence based medicine at the point of care testing.
-
Point of care testing as an essential critical care medicine tool.
-
Point of care testing is an important resource tool for practicing family medicine.
Issues Addressed at the TriMark Conference :
-
How to achieve quality in point of care testing.
-
How to implement point of care testing to improve patient outcomes.
-
The impact of molecular diagnostics on point of care testing.
-
Which new technologies will reach the point of care market in the next 2-3 years?
-
Point of care testing in rapid diagnosis of AMI in the ED.
-
What are the prospects for point of care testing in the future?
-
How is technology innovation facilitating the transition of POC testing into standard healthcare practice?
Top Five Reasons To Attend the TriMark Conference :
-
Discover the point of care sectors with the greatest impact on patient care.
-
Identify the key players in the point of care market and recognize how their technology platforms can energize point of care testing.
-
Understand the factors driving growth of the point of care market, which represents over 30% of global in vitro diagnostics sales.
-
Discover the future of point of care testing.
-
See the top innovators in point of care testing technology.
Schedule:
Agenda:
8:00 am 9:00 am Registration and Continental Breakfast
9:00 am 9:10 am Welcoming and Introductory Remarks
Joseph Dooley, Ph.D., DABCC, FACB, Editor-in-Chief, TriMark Publications, LLC
9:10 am 10:00 am Keynote Speaker Achieving Quality at the POCT: Changes that are Moving Towards a Risk Management Approach in the ISO and CLIS Standards
James Nichols, Ph.D., DABCC, FACB, Associate Professor of Pathology at Tufts University School of Medicine; Director of Clinical Chemistry for Baystate Health in Springfield, MA
10:00 am 10:30 am Intermission Coffee and Meet the Exhibitors
10:30 am 11:00 am The Evolution of Multianalyte Rapid Testing: Nanogens Nexus Dx Rapid Testing System
Richard Egan, Ph.D., Executive Director, Immunoassay Development Nanogen, Inc.
11:00 am 11:45 am Implementing Point of Care Testing to Improve Patient Outcomes in the Emergency Department
Kent Lewandrowski, M.D., Ph.D., Associate Chief of Pathology and Director of Clinical Services, Massachusetts General Hospital; Associate Professor at Harvard Medical School; Editor-in-Chief: Point of Care: The Journal of Near Patient Testing Technologies
11:45 am 12:15 pm Moving Molecular Diagnostics Closer to Patient Care
Emily S. Winn-Deen, Ph.D., Vice President, Genetics and Oncology R&D, Cepheid
12:15 pm 12:30 pm Visit the Exhibits
12:30 pm 1:30 pm Lunch
1:30 pm 2:00 pm Efficacy of a Multi-Marker, Serial Draw Protocol for the Rapid Diagnosis of AMI in the ED
Howard J. Kirchick, Ph.D., Scientific Affairs Director, Biosite, Inc.
2:00 pm 2:30 pm POCT Glucose - How Do We Measure Up, What Standards Apply & Where Are We Headed?
Jeff DuBois, Vice President, Medical & Scientific Affairs, Nova Biomedical
2:30 pm 2:45 pm Intermission
2:45 pm 3:00 pm Business Changes in the Point of Care Testing Sector: Whats Happening and Why
Joseph Dooley, Ph.D., DABCC, FACB, Editor-in-Chief, TriMark Publications, LLC
3:00 pm 3:30 pm Recent Developments in Point of Care Testing for HIV and Hepatitis
Stephen R. Lee, Ph.D., Executive VP and CSO, OraSure Technologies
3:30 pm 4:00 pm Point of Care Testing for Respiratory Pathogens: Clinical Evidence Supporting Improved Patient Care
Aleta B. Bonner, MD, MSPH, FAAP, Clinical Assistant Professor, Pediatric Emergency Medicine, Dell Children's Medical Center of Central Texas
4:00 pm 4:30 pm Point of Care Testing in the Future
Barbara Goldsmith, Ph.D., DABCC, FACB, President, American Association for Clinical Chemistry
4:30 pm 5:30 pm Conference Sponsors' Vendor Presentations
Roche.
Biosite.
Nova Biomedical.
Nanogen.
Quidel.
5:30 pm 6:00 pm Wine and Cheese
|
